Pharmafile Logo

Lucid Group celebrates a double win at Communiqué 2021

- PMLiVE

Lucid scooped a double win at this year’s Communiqué awards, the first face-to-face industry event since the start of the pandemic – making it an extra-special occasion for everyone attending. Last night was all about connecting with colleagues and celebrating the pioneering and life-transforming work delivered over the last year–a great example of the industry’s resilience and the passion displayed by everyone working within the healthcare communications space.

Lucid Group was delighted to come away with two wins in the following programme categories:

  1. EXCELLENCE IN MEDICAL AFFAIRS – OPERATIONS for Evaluating Value and Impact across Medical Affairs  
  2. EXCELLENCE IN PUBLIC HEALTH COMMUNICATIONS for Insight-led Flu Vaccination Public Activation Campaign:  London VaccScene ‘Share the Moment’

Tanya Goodyear, Director of Innovation and Strategy, commented, “Despite the challenges we have all faced in 2020, not once have our teams wavered in their commitment to bring life-transforming solutions to our clients. Everyone at Lucid is powered by a passion to make a difference in healthcare. It’s in our DNA to create and innovate, to challenge, reframe and solve problems for our clients. I am thrilled that through our strong client partnerships, our combined efforts continue to be recognised, and I’m super excited thinking about what we’ll be able to achieve in the future.”

You can learn more about the winning programmes and what the judges said about them here:

Evaluating Value and Impact Across Medical Affairs

Insight-led Flu Vaccination Public Activation Campaign: London VaccScene ‘Share the Moment’

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD